Dr. Spratt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
30 Duke Medicine Cir
Durham, NC 27710Phone+1 919-613-4333Fax+1 919-684-5743
Summary
- Dr. Susan Spratt is an endocrinologist in Durham, NC and works for Duke Health. She received her medical degree from Harvard Medical School and has been in practice 22 years. She specializes in diabetes, thyroid, and osteoporosis management. She works with population health and improving quality of care given to patients with diabetes.
Education & Training
- Duke University HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1999 - 2002
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1995 - 1998
- Harvard Medical SchoolClass of 1995
Certifications & Licensure
- NC State Medical License 1999 - 2025
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
- American Board of Preventive Medicine Clinical Informatics
Awards, Honors, & Recognition
- NC Diabetes Advisory Council Award 2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Top MD Consumers Checkbook
Clinical Trials
- Eat Well Produce Benefit for Diabetes and Food Insecurity Start of enrollment: 2023 Jun 20
Roles: Contact
Publications & Presentations
PubMed
- Increasing SGLT-2 inhibitor prescribing through an integrated case-finding algorithm guided interdisciplinary intervention.Cindy Leslie A Roberson, Abby F Hoffman, Pamela Cohen, Victoria Lee Jackson, Susan E Spratt
Journal of the American Pharmacists Association. 2024-12-27 - Addressing cost barriers to healthy eating with Eat Well, a prescription produce subsidy, for patients with diabetes and at risk for food insecurity: Study protocol fo...Connor Drake, Isa Granados, Abigail Rader, Amanda Brucker, Sam Hoeffler
Contemporary Clinical Trials. 2024-10-01 - Clinical progress note: Glucagon-like peptide-1 receptor agonists and hospitalized patients.Anjali Ravee, Desiree Burroughs-Ray, Christopher D Jackson, Susan E Spratt, Suchita Shah Sata
Journal of Hospital Medicine. 2024-08-01
Press Mentions
- Could Dark Chocolate Reduce Your Risk of Diabetes?December 5th, 2024
- In New Trial, Zepbound Bests Wegovy for Weight LossDecember 4th, 2024
- Zepbound Results in More Weight Loss Than Wegovy in the Trial, Says Eli LillyDecember 4th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: